Tyson Foods, Inc.
Tyson Foods, Inc. (TSN) Financial Performance & Income Statement Overview
Explore the financials of Tyson Foods, Inc. (TSN), including yearly and quarterly data on income, cash flow, and balance sheets.
Tyson Foods, Inc. (TSN) Income Statement & Financial Overview
Review Tyson Foods, Inc. TSN income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $13.62B | $13.56B | $13.35B | $13.07B |
| Cost of Revenue | $12.53B | $12.51B | $12.47B | $12.21B |
| Gross Profit | $1.09B | $1.06B | $884.00M | $866.00M |
| Gross Profit Ratio | $0.08 | $0.08 | $0.07 | $0.07 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $515.00M | $535.00M | $537.00M | $554.00M |
| Operating Expenses | $515.00M | $535.00M | $537.00M | $554.00M |
| Total Costs & Expenses | $13.04B | $13.04B | $13.01B | $12.76B |
| Interest Income | $25.00M | $29.00M | $36.00M | $14.00M |
| Interest Expense | $120.00M | $130.00M | $135.00M | $111.00M |
| Depreciation & Amortization | $348.00M | $318.00M | $360.00M | $349.00M |
| EBITDA | $946.00M | $923.00M | $748.00M | $755.00M |
| EBITDA Ratio | $0.07 | $0.07 | $0.06 | $0.05 |
| Operating Income | $580.00M | $525.00M | $341.00M | $312.00M |
| Operating Income Ratio | $0.04 | $0.04 | $0.03 | $0.02 |
| Other Income/Expenses (Net) | -$102.00M | -$50.00M | -$88.00M | -$109.00M |
| Income Before Tax | $478.00M | $475.00M | $253.00M | $203.00M |
| Income Before Tax Ratio | $0.04 | $0.04 | $0.02 | $0.02 |
| Income Tax Expense | $112.00M | $111.00M | $57.00M | $55.00M |
| Net Income | $359.00M | $357.00M | $191.00M | $145.00M |
| Net Income Ratio | $0.03 | $0.03 | $0.01 | $0.01 |
| EPS | $1.01 | $1.03 | $0.54 | $0.42 |
| Diluted EPS | $1.01 | $1.00 | $0.55 | $0.41 |
| Weighted Avg Shares Outstanding | $355.00M | $346.60M | $356.001M | $354.00M |
| Weighted Avg Shares Outstanding (Diluted) | $357.00M | $357.00M | $347.00M | $355.00M |
The company's financials show resilient growth, with revenue advancing from $13.07B in Q2 2024 to $13.62B in Q1 2025. Gross profit remained healthy with margins at 8% in Q1 2025 compared to 7% in Q2 2024. Operating income hit $580.00M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $946.00M. Net income rose to $359.00M, while earnings per share reached $1.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan